Henrietta Lacks HeLa Cell Line: Consent, Race, and Medical Research (1951)
Introduction
Henrietta Lacks was a 31-year-old Black tobacco farmer from Clover, Virginia, when she was diagnosed with cervical cancer at Johns Hopkins Hospital in Baltimore in January 1951. During her treatment, a tissue sample was taken from her tumour — without her knowledge or consent, though this was standard medical practice at the time. That sample became one of the most consequential biological specimens in the history of medicine.
The HeLa Cell Line
Researcher George Gey at Johns Hopkins cultured cells from Lacks''s biopsy and discovered they behaved unlike any human cells previously observed: they did not die. Normal human cells divide a limited number of times before dying; Lacks''s cancer cells divided indefinitely under laboratory conditions. Gey named the cell line ''HeLa'' (from Henrietta Lacks) and shared samples with researchers around the world at no charge.
The HeLa cell line was instrumental in Jonas Salk''s development of the polio vaccine in 1952. It has since been used in research on HPV and cervical cancer causation, in-vitro fertilization techniques, cancer biology, radiation effects, and — decades later — COVID-19 vaccine development. HeLa cells have been used in more than 70,000 published scientific studies.
The Family''s Exclusion
Henrietta Lacks died on 4 October 1951, eight months after her diagnosis. Her family was not informed that her cells had been cultured, distributed, and commercialized. They learned of the cell line''s existence only in 1973, when researchers studying the HeLa genome contacted family members for genetic comparison samples — again without adequate explanation of the implications.
Rebecca Skloot''s ''The Immortal Life of Henrietta Lacks'' (Crown, 2010) brought the case to mass public attention, describing both the scientific significance of HeLa cells and the Lacks family''s complete exclusion from the commercial and scientific benefits derived from Henrietta''s tissue. An HBO documentary adaptation, produced by Oprah Winfrey, was released in 2017.
Consent, Race, and Medical Ethics
The absence of informed consent was not anomalous in 1951 — patients routinely had tissue taken without specific consent for research use. But the case became a landmark in debates about informed consent, bodily autonomy, bioethics, and the intersection of race and medicine. The Lacks case is now taught in medical and bioethics curricula as a foundational example of how marginalized patients — particularly Black Americans — have historically borne the costs of medical advancement without sharing its benefits.
The racial dimension is inseparable from the case''s significance. Johns Hopkins served a largely Black patient population in a segregated Baltimore, and the tissue was taken from a patient who had no meaningful ability to negotiate the terms of her care.
Commercial Exploitation and Legal Resolution
HeLa cells became a commercial product. Biotech and pharmaceutical companies, including Thermo Fisher Scientific, commercialized HeLa-derived research tools. On 1 August 2023, the Lacks family reached a settlement with Thermo Fisher Scientific — the amount was not disclosed publicly, but the settlement was the first time a company had been held legally accountable for commercial use of HeLa cells. The case was brought by the family''s attorney and represented the first major legal resolution in over 70 years of commercial HeLa use.
Verdict
Confirmed. The non-consensual tissue collection, the cell line''s commercial and scientific use, the family''s exclusion, and the racial context are all thoroughly documented. The 2023 settlement acknowledges commercial exploitation in legal terms. The case represents a confirmed instance of a Black patient''s biological material being appropriated without consent or compensation for decades of profitable use.
What Further Research Should Examine
- Full scope of HeLa commercialization and whether other companies follow Thermo Fisher in reaching settlements
- Federal policy on compensation and consent for biospecimen research use
- Broader reckoning with historical non-consensual tissue collection from Black and incarcerated patients
Evidence Filters8
Tissue taken without informed consent, 8 February 1951
SupportingStrongA biopsy of Henrietta Lacks's cervical tumour was taken at Johns Hopkins Hospital on 8 February 1951 without specific consent for research use. While this was standard medical practice at the time, the absence of consent became central to bioethics debates about patient rights and research use of human tissue.
HeLa: first immortal human cell line — used in 70,000+ studies
SupportingStrongGeorge Gey's cultivation of HeLa cells produced the first human cell line that could be sustained and replicated indefinitely in a laboratory. The cell line has been used in more than 70,000 published scientific studies across multiple decades and disciplines.
HeLa critical to Salk polio vaccine (1952)
SupportingStrongJonas Salk's development of the polio vaccine relied on mass production of the virus using HeLa cells, which could be grown in large quantities unlike primary cell cultures available at the time. The HeLa cell line's role in the polio vaccine's development is documented in published scientific literature.
Family unaware of HeLa existence until 1973
SupportingStrongTwenty-two years after Henrietta Lacks's death, her family was first contacted by researchers studying the HeLa genome. The family had no knowledge that her cells had been cultured, distributed globally, and commercialized for over two decades. The manner of the disclosure was itself poorly handled.
Rebecca Skloot 'The Immortal Life of Henrietta Lacks' (Crown 2010)
SupportingStrongSkloot's rigorously reported book brought the Henrietta Lacks case to mass public attention, documenting both the scientific significance of HeLa and the family's complete exclusion from the benefits. The book spent more than two years on the New York Times bestseller list and is now standard bioethics reading.
2023 family settlement with Thermo Fisher Scientific
SupportingStrongOn 1 August 2023, the Lacks family reached a settlement with Thermo Fisher Scientific over commercial use of HeLa-derived products. The settlement amount was undisclosed but represented the first time a company was held legally accountable for commercializing HeLa cells without family consent or compensation.
Racial context: Black patient in segregated Baltimore hospital
SupportingStrongHenrietta Lacks was treated at Johns Hopkins in a segregated ward. The racial and economic position of Black patients in mid-century American medicine — with limited ability to negotiate care terms and disproportionate exposure to research without consent — is inseparable from the case's significance.
Consent was standard practice at time — nuancing the legal claim
DebunkingNon-consensual tissue collection for research was legally standard in 1951. The Lacks case is widely taught not as a simple crime but as an illustration of how legal standards can embed structural inequality. Moore v. Regents of UC (1990) later ruled patients do not own tissue once removed, complicating legal remedies.
Rebuttal
The legal nuance does not diminish the ethical harm. The 2023 Thermo Fisher settlement acknowledges that continued commercial exploitation — long after consent norms changed — exceeded what legal or ethical standards could justify.
Evidence Cited by Believers7
Tissue taken without informed consent, 8 February 1951
SupportingStrongA biopsy of Henrietta Lacks's cervical tumour was taken at Johns Hopkins Hospital on 8 February 1951 without specific consent for research use. While this was standard medical practice at the time, the absence of consent became central to bioethics debates about patient rights and research use of human tissue.
HeLa: first immortal human cell line — used in 70,000+ studies
SupportingStrongGeorge Gey's cultivation of HeLa cells produced the first human cell line that could be sustained and replicated indefinitely in a laboratory. The cell line has been used in more than 70,000 published scientific studies across multiple decades and disciplines.
HeLa critical to Salk polio vaccine (1952)
SupportingStrongJonas Salk's development of the polio vaccine relied on mass production of the virus using HeLa cells, which could be grown in large quantities unlike primary cell cultures available at the time. The HeLa cell line's role in the polio vaccine's development is documented in published scientific literature.
Family unaware of HeLa existence until 1973
SupportingStrongTwenty-two years after Henrietta Lacks's death, her family was first contacted by researchers studying the HeLa genome. The family had no knowledge that her cells had been cultured, distributed globally, and commercialized for over two decades. The manner of the disclosure was itself poorly handled.
Rebecca Skloot 'The Immortal Life of Henrietta Lacks' (Crown 2010)
SupportingStrongSkloot's rigorously reported book brought the Henrietta Lacks case to mass public attention, documenting both the scientific significance of HeLa and the family's complete exclusion from the benefits. The book spent more than two years on the New York Times bestseller list and is now standard bioethics reading.
2023 family settlement with Thermo Fisher Scientific
SupportingStrongOn 1 August 2023, the Lacks family reached a settlement with Thermo Fisher Scientific over commercial use of HeLa-derived products. The settlement amount was undisclosed but represented the first time a company was held legally accountable for commercializing HeLa cells without family consent or compensation.
Racial context: Black patient in segregated Baltimore hospital
SupportingStrongHenrietta Lacks was treated at Johns Hopkins in a segregated ward. The racial and economic position of Black patients in mid-century American medicine — with limited ability to negotiate care terms and disproportionate exposure to research without consent — is inseparable from the case's significance.
Counter-Evidence1
Consent was standard practice at time — nuancing the legal claim
DebunkingNon-consensual tissue collection for research was legally standard in 1951. The Lacks case is widely taught not as a simple crime but as an illustration of how legal standards can embed structural inequality. Moore v. Regents of UC (1990) later ruled patients do not own tissue once removed, complicating legal remedies.
Rebuttal
The legal nuance does not diminish the ethical harm. The 2023 Thermo Fisher settlement acknowledges that continued commercial exploitation — long after consent norms changed — exceeded what legal or ethical standards could justify.
Timeline
Cervical cancer tissue taken from Henrietta Lacks at Johns Hopkins
A biopsy sample from Henrietta Lacks's cervical tumour is taken during her treatment at Johns Hopkins Hospital. Researcher George Gey's laboratory receives the sample and begins attempting to culture the cells — unbeknownst to Lacks or her family.
Henrietta Lacks dies; family unaware of HeLa existence
Lacks dies of metastatic cervical cancer at age 31. Her family is not informed that her cells have been cultured and are already being shared with laboratories around the world. HeLa cells are in the process of being used in Jonas Salk's polio vaccine research.
Rebecca Skloot publishes 'The Immortal Life of Henrietta Lacks'
Crown Publishers releases Skloot's decade-in-the-making account of Lacks's life, her cells, and her family's exclusion from the scientific and commercial benefits of HeLa. The book becomes a bestseller and enters bioethics curricula worldwide. An HBO adaptation follows in 2017.
Source →Lacks family settles with Thermo Fisher Scientific
The Lacks family reaches a settlement with Thermo Fisher Scientific over commercial use of HeLa cells. The amount is undisclosed. It is the first time a company has been held legally accountable for commercial exploitation of the HeLa cell line — 72 years after the tissue was originally taken.
Source →
Verdict
Cervical cancer tissue taken from Henrietta Lacks at Johns Hopkins on 8 February 1951 without informed consent (standard practice at the time). George Gey cultured first immortal human cell line (HeLa). Used in Salk polio vaccine (1952), HPV research, IVF, and COVID vaccine development. Family unaware until 1973. Rebecca Skloot 'The Immortal Life of Henrietta Lacks' (Crown 2010); HBO 2017. Aug 1 2023 family settlement with Thermo Fisher Scientific (undisclosed). First legal accountability for commercial HeLa use.
Frequently Asked Questions
Did Henrietta Lacks consent to having her cells used for research?
No. A tissue sample was taken from Lacks's cervical tumour during her treatment at Johns Hopkins on 8 February 1951 without specific consent for research use. This was standard medical practice at the time — patients did not routinely consent to research use of removed tissue. The absence of consent became foundational to bioethics reform in subsequent decades.
What have HeLa cells been used for?
HeLa cells were instrumental in Jonas Salk's development of the polio vaccine in 1952. They have since been used in research on HPV and cervical cancer, in-vitro fertilization, radiation effects, cancer biology, and COVID-19 vaccine development. More than 70,000 published scientific studies have used HeLa cells across more than seven decades.
Did the Lacks family benefit financially from HeLa cells?
For most of the cell line's history, the family received no compensation. HeLa cells became a commercial product generating significant revenue for biotech companies. The family reached a settlement with Thermo Fisher Scientific on 1 August 2023 — the first time any company was held legally accountable for commercial HeLa use. The settlement amount was not disclosed.
When did the Lacks family find out about HeLa cells?
The family first learned of the cell line's existence in 1973, 22 years after Henrietta Lacks's death, when researchers studying the HeLa genome contacted family members for genetic comparison samples. The disclosure was poorly handled and the family had little understanding of the implications. Rebecca Skloot's 2010 book provided the first comprehensive public account of their experience.
Sources
Show 3 more sources
Further Reading
- bookThe Immortal Life of Henrietta Lacks — Rebecca Skloot (2010)
- documentaryHBO documentary: The Immortal Life of Henrietta Lacks (2017) — George C. Wolfe (2017)
- articleLacks family settlement with Thermo Fisher Scientific — NYT coverage — New York Times (2023)